Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Gen-Probe Files for US Regulatory Clearance of PANTHERâ„¢ System, Fully Automated and Integrated Molecular Testing Instrument

May 20, 2011 By Bio-Medicine.Org

SAN DIEGO, May 20, 2011 /PRNewswire/ — Gen-Probe
Incorporated (NASDAQ:
GPRO
) announced today that the Company has filed a 510(k)
application with the US Food and Drug Administration for its
PANTHER™ system, a fully automated and integrated molecular
testing system designed with the flexibility to handle a wide range
of testing needs.

“Filing our US regulatory application for the PANTHER system
on-time is another important milestone in our efforts to create
differentiated value for our laboratory customers,” said Carl Hull,
Gen-Probe’s president and chief executive officer.  “We
believe the PANTHER system will revolutionize molecular diagnostics
by offering customers high levels of productivity and instrument
flexibility that were once reserved for high-throughput clinical
chemistry and immunoassay systems.”

Gen-Probe filed for regulatory clearance to run the APTIMA Combo
2® assay, the Company’s market-leading dual test for the common
sexually transmitted infections Chlamydia and gonorrhea, on the
PANTHER system.  Several other qualitative and quantitative
assays are being developed for the system.  Over time, these
new assays will enable customers to increase efficiency by
consolidating testing on the PANTHER platform.

Key features of the PANTHER system include:

  • Fully integrated “sample-in, result-out” automation.  A
    single operator can process 275 samples in eight hours on the
    PANTHER system, yielding 550 Chlamydia and gonorrhea results with
    the APTIMA Combo 2 assay.  Hands-on time is less than an hour,
    resulting in more than seven hours of walk-away freedom.  For
    larger customers, the PANTHER system can continue running
    unattended, processing 500 samples (1,000 Chlamydia and gonorrhea
    results) in 12 hours.  These automation features can help
    laboratory customers man

    ‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech